These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7871640)

  • 1. Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.
    Atmani F; Lacour B; Jungers P; Drüeke T; Daudon M
    Urol Res; 1994; 22(4):257-60. PubMed ID: 7871640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.
    Atmani F; Lacour B; Drüeke T; Daudon M
    Urol Res; 1993 Jan; 21(1):61-6. PubMed ID: 8456540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.
    Atmani F; Khan SR
    Urol Res; 1995; 23(2):95-101. PubMed ID: 7676539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
    Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
    Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
    Jaggi M; Nakagawa Y; Zipperle L; Hess B
    Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
    Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
    Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian periodicity of urinary inhibitor of calcium oxalate crystallization in healthy Indians and renal stone formers.
    Singh RK; Bansal A; Bansal SK; Singh AK; Mahdi AA
    Eur Urol; 1993; 24(3):387-92. PubMed ID: 8262108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor.
    Atmani F; Mizon J; Khan SR
    Eur J Biochem; 1996 Mar; 236(3):984-90. PubMed ID: 8665922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial biochemical and physicochemical characterization of organic macromolecules in urine from patients with renal stones and control subjects.
    Kitamura T; Zerwekh JE; Pak CY
    Kidney Int; 1982 Feb; 21(2):379-86. PubMed ID: 7070000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective urinary crystallization inhibition and urinary stone formation.
    Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
    Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.